{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,11]],"date-time":"2026-10-11T02:09:55Z","timestamp":1791684595315,"version":"4.3.4"},"update-to":[{"DOI":"10.1002\/14651858.cd003643.pub3","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2012,8,15]],"date-time":"2012-08-15T00:00:00Z","timestamp":1344988800000}}],"reference-count":45,"publisher":"Wiley","issue":"8","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003643.pub4","type":"journal-article","created":{"date-parts":[[2012,8,8]],"date-time":"2012-08-08T11:25:25Z","timestamp":1344425125000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis"],"prefix":"10.1002","volume":"2016","author":[{"given":"Patrick A","family":"Gordon","sequence":"first","affiliation":[{"name":"Kings College Hospital; Department of Rheumatology; Denmark Hill London UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Winer","sequence":"additional","affiliation":[{"name":"Queen Elizabeth Hospital; Department of Neurology; Edgbaston Birmingham UK B15 2TH"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica E","family":"Hoogendijk","sequence":"additional","affiliation":[{"name":"University Hospital Utrecht; Neurology; Heidelberglaan 100 3584 CX Utrecht Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernest HS","family":"Choy","sequence":"additional","affiliation":[{"name":"Cardiff University School of Medicine; Section of Rheumatology, Division of Infection and Immunity; Tenovus Building Heath Park Cardiff UK CF14 4XN"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2012,8,15]]},"reference":[{"issue":"3","key":"10.1002\/14651858.CD003643.pub4-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/0003-4819-92-3-365","article-title":"Azathioprine with prednisone for polymyositis","volume":"92","author":"Bunch","year":"1980","journal-title":"Annals of Internal Medicine"},{"issue":"Suppl","key":"10.1002\/14651858.CD003643.pub4-BIB0002|cit2","first-page":"Abstract No: 20","article-title":"A randomized, double-blind, placebo-controlled trial of infliximab in patients with polymyositis and dermatomyositis","volume":"58","author":"Coyle","year":"2008","journal-title":"Arthritis and Rheumatism"},{"issue":"27","key":"10.1002\/14651858.CD003643.pub4-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJM199312303292704","article-title":"A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis","volume":"329","author":"Dalakas","year":"1993","journal-title":"New England Journal of Medicine"},{"issue":"21","key":"10.1002\/14651858.CD003643.pub4-BIB0004|cit4","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1056\/NEJM199205213262102","article-title":"Controlled trial of plasma exchange and leukapheresis in polymyositis and dermatomyositis","volume":"326","author":"Miller","year":"1992","journal-title":"New England Journal of Medicine"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD003643.pub4-BIB0005|cit5","first-page":"S53","article-title":"Randomised double blind controlled trial of methotrexate and steroids compared with azathioprine and steroids in the treatment of idiopathic inflammatory myopathy","volume":"199","author":"Miller","year":"2002","journal-title":"Journal of the Neurological Sciences"},{"issue":"3","key":"10.1002\/14651858.CD003643.pub4-BIB0006|cit6","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1002\/ana.22477","article-title":"A randomized, pilot trial of etanercept in dermatomyositis","volume":"70","author":"Muscle Study Group","year":"2011","journal-title":"Annals of Neurology"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0007|cit7","unstructured":"NCT00112385 A pilot study of etanercept in dermatomyositis http:\/\/clinicaltrials.gov\/ct2\/show\/results\/NCT00112385"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0008|cit8","first-page":"S489","article-title":"A pilot study of eculizumab in patients with dermatomyositis","volume":"46 (Suppl)","author":"Takada","year":"2002","journal-title":"Arthritis and Rheumatism"},{"issue":"6","key":"10.1002\/14651858.CD003643.pub4-BIB0009|cit9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.nmd.2010.03.011","article-title":"Oral dexamethasone pulse therapy versus daily prednisolone in sub-acute onset myositis, a randomised clinical trial","volume":"20","author":"Vlekkert","year":"2010","journal-title":"Neuromuscular Disorders"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub4-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1080\/030097400750001897","article-title":"Cyclosporine A versus methotrexate in the treatment of polymyositis and dermatomyositis","volume":"29","author":"Vencovsk\u00fd","year":"2000","journal-title":"Scandinavian Journal of Rheumatology"},{"issue":"3","key":"10.1002\/14651858.CD003643.pub4-BIB0011|cit11","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/1529-0131(199803)41:3<392::AID-ART3>3.0.CO;2-X","article-title":"Treatment of refractory myositis: a randomized crossover study of two new cytotoxic regimens","volume":"41","author":"Villalba","year":"1998","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub4-BIB0012|cit12","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1002\/art.1780240107","article-title":"Prednisone and azathioprine for polymyositis: long-term follow up","volume":"24","author":"Bunch","year":"1981","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/art.22687","article-title":"Creatine supplements in patients with idiopathic inflammatory myopathies who are clinically weak after conventional pharmacologic treatment: Six-month, double-blind, randomized, placebo-controlled trial","volume":"57","author":"Chung","year":"2007","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0014|cit14","first-page":"561","article-title":"Experimental use of plasmapheresis in juvenile dermatomyositis therapy","volume":"13 Suppl 13","author":"Donov","year":"1995","journal-title":"Clinical & Experimental Rheumatology"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub4-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.1780160204","article-title":"Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis","volume":"16","author":"Fries","year":"1973","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0016|cit16","unstructured":"ISRCTN40085050 Second line agents in myositis http:\/\/www.controlled-trials.com\/ISRCTN40085050"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0017|cit17","unstructured":"NCT00001261 Intravenousimmunoglobulin (IVIg) for the treatment of inflammatory myopathies http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00001261"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0018|cit18","unstructured":"NCT00035958 Understanding the pathogenesis and treatment of childhood onset dermatomyositis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00035958"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0019|cit19","unstructured":"NCT00106184 Rituximab for the treatment of refractory adult and juvenile dermatomyositis (DM) and adult polymyositis (PM) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00106184"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0020|cit20","unstructured":"NCT00323960 Five-year actively controlled clinical trial in new onset juvenile dermatomyositis (PRINTOJDMTR) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00323960"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0021|cit21","unstructured":"NCT00335985 Efficacy and safety study of GB-0998 for treatment of steroid-resistant polymyositis and dermatomyositis (PM\/DM) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00335985"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0022|cit22","unstructured":"NCT00533091 A study to evaluate safety of multi-dose MEDI-545 in adult patients with dermatomyositis or polymyositis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00533091"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0023|cit23","unstructured":"NCT00651040 Combined treatment of methotrexate + glucocorticoids versus glucocorticoids alone in patients with polymyositis and dermatomyositis (Prometheus) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT00651040"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0024|cit24","unstructured":"NCT01148810 Efficacy and tolerability of BAF312 in patients with polymyositis and dermatomyositis http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01148810"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0025|cit25","unstructured":"NCT01315938 Abatacept treatment in polymyositis and dermatomyositis (ARTEMIS) http:\/\/clinicaltrials.gov\/ct2\/show\/NCT01315938"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub4-BIB0026|cit26","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000110327","article-title":"Epidemiology of neuromuscular diseases, including the postpolio sequelae, in a Swedish county","volume":"12","author":"Ahlstrom","year":"1993","journal-title":"Neuroepidemiology"},{"issue":"7","key":"10.1002\/14651858.CD003643.pub4-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM197502132920706","article-title":"Polymyositis and dermatomyositis (first of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD003643.pub4-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJM197502202920807","article-title":"Polymyositis and dermatomyositis (second of two parts)","volume":"292","author":"Bohan","year":"1975","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub4-BIB0029|cit29","first-page":"207","article-title":"Survival in polymyositis: corticosteroids and risk factors","volume":"4","author":"Carpenter","year":"1977","journal-title":"Journal of Rheumatology"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub4-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/41.1.7","article-title":"Treatment of dermatomyositis and polymyositis","volume":"41","author":"Choy","year":"2002","journal-title":"Rheumatology"},{"issue":"21","key":"10.1002\/14651858.CD003643.pub4-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1056\/NEJM199111213252107","article-title":"Polymyositis, dermatomyositis, and inclusion-body myositis","volume":"325","author":"Dalakas","year":"1991","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub4-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1136\/jnnp.70.5.569","article-title":"Progress in inflammatory myopathies: good but not good enough","volume":"70","author":"Dalakas","year":"2001","journal-title":"Journal of Neurology, Neurosurgery and Psychiatry"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0033|cit33","unstructured":"Higgins JPT Green S (editors) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011] The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub4-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.nmd.2004.02.006","article-title":"119th ENMC international workshop: trial design in adult idiopathic inflammatory myopathies, with the exception of inclusion body myositis, 10-12 October 2003, Naarden, The Netherlands","volume":"14","author":"Hoogendijk","year":"2004","journal-title":"Neuromuscular Disorders"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub4-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/rheumatology\/keg427","article-title":"International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease","volume":"43","author":"Isenberg","year":"2004","journal-title":"Rheumatology"},{"issue":"4","key":"10.1002\/14651858.CD003643.pub4-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0002-9343(93)90148-I","article-title":"Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine and methotrexate and a comparison of their efficacy","volume":"94","author":"Joffe","year":"1993","journal-title":"American Journal of Medicine"},{"issue":"9","key":"10.1002\/14651858.CD003643.pub4-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/art.21291","article-title":"International consensus guidelines for trials of therapies in the idiopathic inflammatory myopathies","volume":"52","author":"Oddis","year":"2005","journal-title":"Arthritis and Rheumatism"},{"key":"10.1002\/14651858.CD003643.pub4-BIB0038|cit38","unstructured":"The Nordic Cochrane Centre, The Cochrane Collaboration Review Manager (RevMan) 2011"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub4-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0022-510X(75)90115-X","article-title":"Prognosis in adult polymyositis","volume":"26","author":"Riddoch","year":"1975","journal-title":"Journal of the Neurological Sciences"},{"issue":"7","key":"10.1002\/14651858.CD003643.pub4-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1002\/art.20349","article-title":"International consensus on preliminary definitions of improvement in adult and juvenile myositis","volume":"50","author":"Rider","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"1","key":"10.1002\/14651858.CD003643.pub4-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/art.20078","article-title":"Quality of myositis case reports open to improvement","volume":"51","author":"Vlekkert","year":"2004","journal-title":"Arthritis and Rheumatism"},{"issue":"5","key":"10.1002\/14651858.CD003643.pub4-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/01.STR.19.5.604","article-title":"Interobserver agreement for the assessment of handicap in stroke patients","volume":"19","author":"Swieten","year":"1988","journal-title":"Stroke"},{"issue":"2","key":"10.1002\/14651858.CD003643.pub4-BIB0043|cit43","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003643","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"3","key":"10.1002\/14651858.CD003643.pub4-BIB0044|cit44","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003643.pub2","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"4","key":"10.1002\/14651858.CD003643.pub4-BIB0045|cit45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003643.pub3","article-title":"Immunosuppressant and immunomodulatory treatment for dermatomyositis and polymyositis","author":"Choy","year":"2009","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full\/10.1002\/14651858.CD003643.pub4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,7]],"date-time":"2023-08-07T14:33:02Z","timestamp":1691418782000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003643.pub4"}},"subtitle":[],"editor":[{"name":"Cochrane Neuromuscular Group","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2012,8,15]]},"references-count":45,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2016,8]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003643.pub4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.717954948.793462217","asserted-by":"object"}]},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,8,15]]}}}